Archive
Nov 29, 2022 11:45 AM EST
Nov 16, 2022 10:15 AM EST
Nov 3 - Nov 4, 2022
The Retina Society - 55th Annual Scientific Meeting
These slides contain the 48-week data from the Phase 2/3 PHOTON study (by Dr. David M. Brown) and the Phase 3 PULSAR study (by Jean-François Korobelnik) of aflibercept 8 mg for DME and nAMD, respectively, as presented at the 55th Annual Scientific Session of The Retina Society on November 3-4, 2022.
Nov 3, 2022 8:30 AM EDT
Sep 30, 2022 4:24 PM EDT
American Academy of Ophthalmology 2022 Annual Meeting
These slides contain the 48-week results from the Phase 2/3 PHOTON study (by Dr. David M. Brown) and the Phase 3 PULSAR study (by Dr. Paolo Lanzetta) of aflibercept 8 mg for DME and nAMD, respectively, as presented at AAO 2022 on September 30, 2022.
Sep 12, 2022 11:05 AM EDT
Sep 12, 2022 8:00 AM EDT
Sep 8, 2022 11:00 AM EDT
Aug 3, 2022 8:30 AM EDT